Cell-of-origin insights could deepen understanding of CNS injury and disease progression in multiple sclerosis and related diseases PLEASANT GROVE, Utah, Oct. 1, 2026 /PRNewswire/ -- Renew Biotechnologies today announced a clinical development collaboration with Mayo Clinic to evaluate...